Morbidity and mortality associated with intraperitoneal chemotherapy for Pseudomyxoma peritonei.

Background: Many centers include intraperitoneal chemotherapy for treatment of pseudomyxoma peritonei. This study documented the morbidity of intraperitoneal chemotherapy in a single institution.

Methods: A retrospective review of pseudomyxoma peritonei over a 6-year period was undertaken.